Vestibular Diseases: Clinical Trials

19 trials for Vestibular Diseases, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

12 completed, 4 unknown, 2 withdrawn, 1 terminated. 19 Phase 2, 3 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 219Completed 12, Unknown 4, Withdrawn 2, Terminated 1
Phase 13Completed 2, Unknown 1

Follow Vestibular Diseases: new trials by email Literature Review of Vestibular Diseases trials Research Report on Vestibular Diseases

Trials (filtered) newest first · largest first

All 19 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effect of the Administration of L-arginine vs. Placebo in Patients Diagnosed With Presbyvestibulopathy.
L-arginine, Placebo - Presbyvestibulopathy
Phase 2WithdrawnCentro Universitario de Tonalá2023-05-022024-02-15
Automated Robotic Maneuvering System (RMS) vs Manual Reposition Maneuver in Treatment of Benign Paroxysmal Positional Vertigo (BPPV)
Automated vertigo repositioning chair, Canalith Reposition Maneuver - Benign Paroxysmal Positional Vertigo
Phase 1 / Phase 2CompletedStratejik Yenilikci Girisimler Ltd.752022-02-152022-04-29
Lamotrigine and Bupropion for Meniere's Disease
Lamotrigine and Bupropion, Placebo - Meniere Disease, Ménière's Vertigo
Phase 2UnknownDent Neuroscience Research Center342020-12-162022-06-21
Benign Paroxysmal Positional Vertigo (BPPV) in Older Patients
Vitamin D, Placebo - Benign Paroxysmal Positional Vertigo
Phase 2UnknownChangi General Hospital602020-11-012020-10-09
AM-125 in the Treatment of Acute Peripheral Vertigo Following Neurosurgery
Intranasal Drug, Oral Tablet, Intranasal Placebo - Vestibular Vertigo
Phase 2CompletedAuris Medical AG1242019-07-182023-09-14
4-Aminopyridine, Atenolol, or Placebo in Patients With Vestibular Migraine
4-aminopyridine, Atenolol, Placebo - Vestibular Migraine, Migraine Disorders
Phase 2WithdrawnMassachusetts Eye and Ear Infirmary2019-01-012024-07-01
Acute Video-oculography for Vertigo in Emergency Rooms for Rapid Triage (AVERT)
VRT Care - Vertigo, Dizziness
Phase 2CompletedJohns Hopkins University1302017-12-042025-12-26
SPI-1005 for the Treatment of Patients With Meniere's Disease
200mg SPI-1005 BID, 400mg SPI-1005 BID, Placebo - Meniere's Disease
Phase 2CompletedSound Pharmaceuticals, Incorporated1492017-09-282023-09-18
SPI-1005 for Prevention and Treatment of Tobramycin Induced Ototoxicity
Placebo, SPI-1005 Ebselen 200mg Capsule x1, SPI-1005 Ebselen 200mg Capsule x2 - Ototoxicity
Phase 2CompletedSound Pharmaceuticals, Incorporated352017-07-212026-07-16
Study to Evaluate SPI-1005 in Adults With Meniere's Disease
SPI-1005 - Meniere's Disease
Phase 1 / Phase 2CompletedSound Pharmaceuticals, Incorporated402015-12-012026-06-29
Study of Lamotrigine to Treat Ménière's Disease
Lamotrigine, Placebo - Meniere's Disease, Ménière's Vertigo
Phase 2CompletedDent Neuroscience Research Center152014-06-012022-06-22
A Clinical Trial To Evaluate Efficacy And Safety Of Levophencynonate Hydrochloride In Patient With Vertigo
Levophencynonate Hydrochloric, Placebo - Vertigo
Phase 2CompletedSihuan Pharmaceutical Holdings Group Ltd.982014-01-012016-04-15
OTO-104 for the Treatment of Meniere's Disease
OTO-104, Placebo - Meniere's Disease
Phase 2CompletedOtonomy, Inc.1542013-11-012015-09-03
Latanoprost for the Treatment of Menière's Disease
Latanoprost, Placebo - Menière's Disease
Phase 2UnknownSynphora AB1002013-10-012016-03-23
Treatment of Apogeotropic Horizontal Canal Benign Paroxysmal Positional Vertigo
Gufoni, Vibration, Sham - Benign Paroxysmal Positional Vertigo
Phase 2CompletedKeimyung University Dongsan Medical Center2092013-09-012016-03-11
Efficacy of Extended-release, Once Daily Tramadol for Post Operative Analgesia in Shoulder Arthroscopy
tramadol, Placebo - Pain, Vertigo
Phase 2TerminatedCentre hospitalier de l'Université de Montréal (CHUM)1002013-06-012020-07-24
Visual Feedback Goggle for Positional Vertigo Treatment
Goggle with 20 degree error, Optimized Goggle - Positional Vertigo, Vertigo
Phase 1 / Phase 2UnknownVertigone Inc.602006-11-012008-08-08
Prednisone Treatment for Vestibular Neuronitis
Prednisone - Vestibular Diseases, Vestibular Neuronitis
Phase 2CompletedCarmel Medical Center172005-09-012007-11-06
Treatments for Benign Paroxysmal Positional Vertigo (BPPV)
Canalith repositioning maneuver (Epley maneuver), Semont maneuver, Brandt-Daroff exercises - Vertigo
Phase 2CompletedBaylor College of Medicine1501998-10-012012-07-26

Narrower conditions

Vertigo (15)  ·  Benign Paroxysmal Positional Vertigo (5)  ·  Hearing Loss (5)  ·  Meniere Disease (5)  ·  Tinnitus (5)  ·  Dizziness (4)  ·  Vestibular Neuronitis (2)  ·  Cystic Fibrosis (1)  ·  Emergencies (1)  ·  Migraine Disorders (1)  ·  Nausea (1)  ·  Ototoxicity (1)  ·  Pain (1)  ·  Pruritus (1)

Broader conditions

Ear Diseases (19)  ·  Labyrinth Diseases (19)  ·  Nervous System Diseases (19)  ·  Otorhinolaryngologic Diseases (19)  ·  Neurologic Manifestations (17)  ·  Pathological Conditions, Signs and Symptoms (17)  ·  Signs and Symptoms (17)  ·  Sensation Disorders (9)  ·  Endolymphatic Hydrops (5)  ·  Hearing Disorders (5)  ·  Brain Diseases (2)  ·  Central Nervous System Diseases (2)  ·  Cranial Nerve Diseases (2)  ·  Pathologic Processes (2)

Interventions

ebselen (3)  ·  Lamotrigine (2)  ·  microcrystalline cellulose (2)  ·  4-Aminopyridine (1)  ·  Administration, Intranasal (1)  ·  Arginine (1)  ·  Atenolol (1)  ·  Bupropion (1)  ·  Eye Protective Devices (1)  ·  Latanoprost (1)  ·  Prednisone (1)  ·  Starch (1)  ·  Tablets (1)  ·  Tramadol (1)  ·  Vibration (1)

Sponsors

Sound Pharmaceuticals, Incorporated (3)  ·  Dent Neuroscience Research Center (2)  ·  Auris Medical AG (1)  ·  Baylor College of Medicine (1)  ·  Carmel Medical Center (1)  ·  Centre hospitalier de l'Université de Montréal (CHUM) (1)  ·  Centro Universitario de Tonalá (1)  ·  Changi General Hospital (1)  ·  Johns Hopkins University (1)  ·  Keimyung University Dongsan Medical Center (1)  ·  Massachusetts Eye and Ear Infirmary (1)  ·  Otonomy, Inc. (1)  ·  Sihuan Pharmaceutical Holdings Group Ltd. (1)  ·  Stratejik Yenilikci Girisimler Ltd. (1)  ·  Synphora AB (1)

Countries

United States (10)  ·  Canada (1)  ·  China (1)  ·  France (1)  ·  Israel (1)  ·  Mexico (1)  ·  South Korea (1)  ·  Sweden (1)  ·  Turkey (Türkiye) (1)

Top investigators

Jonathan Kil, MD (3)  ·  Lixin Zhang, MD, PhD (2)  ·  Avi Shupak, MD (1)  ·  Avishai Golz, MD (1)  ·  Carl LeBel, PhD (1)  ·  David Newman-Toker, MD, PhD (1)  ·  Elhanan Greenberg, ND (1)  ·  Helen Cohen, EdD (1)  ·  Hyun Ah Kim (1)  ·  Hyung Lee (1)  ·  Itzhak Braverman, MD (1)  ·  Jean-Denis Roy, Doctor (1)  ·  Mikael Karlberg, MD, PhD (1)  ·  Murat H Ozkul, M.D. (1)

Results publications

PMID 15011204, PMID 15103195, PMID 16151355, PMID 28220291, PMID 32483557, PMID 33675203, PMID 34510123, PMID 37166022

NIH funding

2018 (1), R01DC003602 (1), U01DC013778 (1)